Obrela is recognised, again, in the 2023 Gartner® Market Guide for MDR Services.
PLEASE NOTE THERE IS AN UPDATED REPORT WHERE OBRELA IS INCLUDED AGAIN AND YOU CAN DOWNLOAD IN THIS LINK.
THIS PAGE REFERS TO THE PREVIOUS REPORT THAT IS NOW ACCESSIBLE VIA THE GARTNER WEBSITE
We’re proud to announce that OBRELA Security Industries is recognized in the Feb. 2023 Gartner® Market Guide for MDR Services, for a 2nd time!
You can use a Market Guide to understand how the status of an emerging market aligns with your future plans. In addition, since Gartner® has published over 100 Market Guide research notes, IT and strategic leaders can gain a broad view of many markets, including mature and smaller markets, in an easy-to-read format.1
According to Gartner®, “by 2025, 60% of the organization will be actively using remote threat disruption and containment capabilities delivered directly and the MDR providers, up from 30% today. In addition, technology-centric offerings and vendor-delivered service wrappers (VDSW) that fail to deliver human-driven managed detection and response (MDR) services, are causing challenges for buyers looking to identify and select an outcome driven provider.”2
Gartner® Market Guide for Managed Detection and Response Services, was published 14 February 2023 by Pete Shoard, Al Price Mitchell Schneider, Craig Lawson, Andrew Davies.
GARTNER® is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and is used herein with permission. All rights reserved.
1.Source of statement https://www.gartner.com/en/research/methodologies/market-guide
2.Gartner® does not endorse any vendor, product or service depicted in its research publications and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner® research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner® disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
